Your browser doesn't support javascript.
loading
PHMH, a diarylheptanoid from Alpinia officinarum attenuates VEGF-induced angiogenesis via inhibition of the VEGFR-2 signaling pathway.
Hu, Liubing; Huang, Weihuan; Ding, Yong; Liu, Min; Wang, Mei; Wang, Ying; Zhang, Wei; Li, Yaolan; Ye, Wencai; Li, Manmei; Liu, Zhong.
Afiliação
  • Hu L; Guangdong Provincial Key Laboratory of Bioengineering Medicine, Institute of Biomedicine, College of Life Science and Technology, Jinan University, Guangzhou 510632, People's Republic of China. tliuzh@jnu.edu.cn.
Food Funct ; 10(5): 2605-2617, 2019 May 22.
Article em En | MEDLINE | ID: mdl-31020299
ABSTRACT
The rhizome of Alpinia officinarum Hance, a popular spice used as a condiment in China and Europe, has various reported bioactivities, including anticancer, anti-inflammatory and antioxidant effects. However, its anti-angiogenic activity has not previously been reported. In this study, a diarylheptanoid was isolated from Alpinia officinarum and identified as 1-phenyl-7-(4-hydroxy-3-methoxyphenyl)-4E-en-3-heptanone (PHMH). We demonstrated that PHMH exerts anti-angiogenic activity both in vitro and in vivo. PHMH inhibited vascular endothelial growth factor (VEGF)-induced viability, migration, invasion and tube formation in human umbilical vein endothelial cells (HUVECs) in vitro, and also suppressed VEGF-induced sprout formation of rat aorta ex vivo. Furthermore, PHMH was found to block VEGF-induced vessel formation in mice and suppress angiogenesis in both zebrafish and chorioallantoic membrane models. Mechanistic studies indicated that PHMH inhibited VEGF-induced VEGF receptor-2 (VEGFR-2) auto-phosphorylation and resulted in the blockage of VEGFR-2-mediated signaling cascades in HUVECs, including the Akt/mTOR, ERK1/2, and FAK pathways. Our findings provide new insights into the potential application of PHMH as a therapeutic agent for anti-angiogenesis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Inibidores da Angiogênese / Diarileptanoides / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Fator A de Crescimento do Endotélio Vascular / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Inibidores da Angiogênese / Diarileptanoides / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Fator A de Crescimento do Endotélio Vascular / Neovascularização Patológica Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article